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ABSTRACT 
Background:  Medication Therapy Management (MTM) is a vital resource in reducing medication nonadherence, yet many individuals 
who are eligible for MTM services are unaware of what MTM is and how to enroll.  Little is known about how to best educate patients 
on MTM services and its benefits. Objective: To determine the difference between in-person education community education versus 
brochure community education on MTM services on perceptions of and enrollment in MTM services. Methods:  A pre-post quasi 
experimental study, where patients were allocated to receive information about MTM through an educational brochure or an in-person 
education session and completed survey assessments pre- and post-intervention, was conducted at a federally-qualified health center.  
Patients who were ages 18 years or older, MTM-eligible, and had received no prior MTM service were eligible to participate.  Changes 
in patient perceptions of and enrollment in MTM from pre- to post-intervention were assessed by survey instruments developed for 
this study. Results: A total of 35 patients (brochure=25, in-person=10) were recruited for this study.  Most participants (94.2%) either 
reported having never heard of MTM or not being sure if they had heard of MTM. There were no significant between-group differences 
on pre-survey questions or pre-post within-group changes (p>0.05). There were significant between-group differences on 11 post-
assessment questions and MTM enrollment (p<0.05), with the in-person education group showing improved perceptions and greater 
enrollment. Conclusion: Patients remain largely unaware of MTM services; there is a need for education to increase awareness. Even 
though educating patients in a face-to-face context had a more positive impact on perceptions of MTM and enrollment in MTM, more 
research is needed regarding the best educational methods as it was difficult for patients to find time to attend an educational session.  
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INTRODUCTION 
Medication nonadherence, “the number of doses not taken or 
taken incorrectly that jeopardizes the patient’s therapeutic 
outcome,”1 is a problem that affects all ages and ethnic groups.  
Many patients may struggle with “not having a prescription 
filled, taking an incorrect dose, taking a medication at the 
wrong time, forgetting to take doses, or stopping therapy too 
soon,”1 leading to non-adherence.  Nonadherence is not 
limited to medication therapy alone, but could include lifestyle 
changes and nonpharmacologic treatments, such as exercise, 
smoking cessation, physical therapy and dietary plans. 
However, medication nonadherence remains a major public 
health concern and is referred to as an “invisible epidemic.”1 
Approximately 43% of the general population, 55% of the 
elderly population, and 54% of children and teenagers are non-
adherent to their medications.1  
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Medication nonadherence has a large impact on health care 
costs. For example, it often furthers disease complications, 
causing an increase in costs due to increased medical 
appointments and hospitalizations.  Each year, medication 
adherence issues contribute to nearly 125,000 deaths in the 
United States.2 Non adherence to medications is also 
responsible for up to 69% of medication-related admissions.2 
Medical costs, whether direct or indirect, resulting from 
medication nonadherence have been estimated to be 
between $100 billion to $300 billion annually.2 With the 
number of Americans suffering from a chronic health condition 
projected to grow from 133 million people to 157 million 
people by the year 2020, there is a pressing need to find a 
solution to medication nonadherence.2 
 
Researchers have found that factors of medication 
nonadherence fall into two broad categories: patient beliefs 
about their medication and practical barriers. The first 
category includes patients’ perceptions about the risks, 
benefits, and efficacy of their medication formed by various 
influences such as personal experience, relationships, and 
communication with healthcare providers.3 Patients must 
believe they actually have a disease and are susceptible to its 
consequences and also believe the recommended therapy will 
reduce the risks of their condition in order for them to be 
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adherent.4 Adherence decreases if these beliefs are not 
established with the aid of proper communication with 
healthcare providers. 
 
Practical barriers include side effects, number of medications, 
frequency of dosing, complexity of therapy, and cost.3 
Research shows that a decline in socioeconomic status, 
increased duration of treatment, number of medications, 
frequency of dosing, and cost are all associated with decreased 
adherence.5,6 Patients who take medications for shorter 
periods of time tend to have greater adherence, whereas 
those patients on long-term or complicated therapy regimens 
have decreased adherence.4,7 Increased cost of medication 
leads to decreased adherence especially in patients with low 
income or low insurance coverage for prescription 
medications.8 Other factors such as demographics and disease 
state have also been considered as factors for non-adherence 
but have generally been found to be poor predictors of 
compliance.4 Much of the patient belief and practical barriers 
that inhibit medication adherence can be addressed through a 
medication therapy management (MTM) service, which 
“optimizes therapeutic outcomes for individual patients.”9 
 
MTM services include a broad range of professional activities 
and responsibilities within the scope of pharmacy practice in a 
face-to-face setting or over the phone, provided by a 
pharmacist or other qualified healthcare professional.9 MTM 
includes services such as comprehensive medication reviews 
(CMR), medication action plans, and immunizations.  Since 
MTM services became reimbursable as a part of Medicare Part 
D after the Medicare Modernization Act in 2004, pharmacists 
have made a significant impact on the problem of medication 
nonadherence.10,11 Indeed, one of the major goals of the 
provision for MTM under Medicare Part D was to improve 
patient medication adherence.12 Various studies support the 
finding that MTM services decrease patient medication 
nonadherence. A randomized controlled trial showed that the 
MTM intervention group had a higher rate of adherence and 
higher percentage of individuals who took their medication on 
time when compared to the usual care group.13 In addition, a 
retrospective cohort showed improvements in medication 
adherence for patients taking medications for various chronic 
conditions.14 Finally, a review of randomized controlled trials 
concluded, “The provision of MTM services by a pharmacist 
within a primary care medical home model can improve 
medication use in an ambulatory care setting.”15 A primary 
care medical home has been defined as “a model of care in 
which the primary care provider coordinates the services 
provided by multiple health care providers, including 
pharmacy services, for patients.”15 With this evidence, it is 
reasonable to conclude that MTM is a vital resource in the 
effort to reduce medication nonadherence.  
 
Despite the significant evidence of the potential benefits of 
MTM and its impact on medication nonadherence, many of 
those individuals eligible for MTM services are not aware of 
MTM and are not being referred by healthcare providers. In a 
study conducted to explore the awareness of Medicare Part D 
enrollees regarding MTM, researchers examined patients’ 
expectations and perceptions of pharmacists in providing 
MTM. It was found that 93% of participants were unaware of 
MTM services, and 70% of respondents did not believe they 
needed MTM services.16 Another study determined patients' 
perceptions and expectations about the core elements of an 
MTM service in the community pharmacy setting. This study 
attempted to develop educational strategies and outreach 
programs that were aimed at increasing patients' knowledge 
of MTM services and the expanded role of pharmacists in the 
community pharmacy setting. Results showed that 60% of 
participants had never heard of MTM services, and patients 
had very limited knowledge of the core elements of an MTM 
service in the community pharmacy setting.17 
 
Little is known on how to best educate patients on MTM 
services and its benefits in order to improve perceptions of and 
enrollment in MTM. Some research has also recently targeted 
their outcomes at discovering which method of 
communication (telephone, face-to-face, “bag-stuffer,” or 
mailed letter) is more effective at enrolling a patient in an 
MTM session. While the researchers found no significant 
difference between their methods of communication, they did 
find that the majority of patients who agreed to have an MTM 
appointment were in the telephone group. The group that 
received a “bag stuffer” with information about MTM saw no 
response.18 Thus, the purpose of this project was to determine 
the most beneficial method of educating patients about MTM 
services and which method increases enrollment the most.  An 
educational event was planned with the intent of creating a 
face-to-face opportunity for patients to learn more about what 
MTM services entail, interact with that information by asking 
questions, and enroll in an MTM session if desired. A brochure-
style approach was chosen as the other intervention to provide 
patients with a more convenient method (less time-intensive) 
of obtaining information about MTM services. The objectives 
were to determine the effect that different types of 
community education (brochure versus in-person education) 
on MTM services have on (1) perceptions of MTM services and 
(2) enrollment in MTM services. 
 
METHODOLOGY 
A pre-post quasi-experimental study was conducted to 
measure patient perceptions of MTM services and their 
enrollment in an MTM service before and after an educational 
intervention. Two different educational interventions were 
used for purposes of comparison. One intervention used was 
an interactive educational event (hereafter called in-person 
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education), while the other intervention was an informational 
brochure (hereafter called brochure) distributed by mail.  
Cedarville University Institutional Review Board approval was 
obtained prior to the study. 
 
Participants were recruited from the Rocking Horse Center, 
Springfield, Ohio (a Federally-Qualified Health Center).  The 
inclusion criteria were: age 18 or older, insured by either 
Medicaid or Medicare Part D, eligible for MTM services (as 
identified through the OutcomesMTM platform), and had 
never previously received an MTM service.  A list of eligible 
patients was obtained (n=389) and called over the telephone 
using a pre-formatted calling script. Verbal consent to 
participate in the study was obtained during this phone call. 
 
After verbal consent, participants were distributed to the in-
person education or brochure group based on their ability and 
willingness to attend the in-person educational event.  
Individuals were first asked if they were willing to attend the 
in-person education. If not, they were asked if they were 
willing to receive an educational brochure in the mail. Those 
individuals not willing to attend an educational event or 
receive an informational brochure in the mail were excluded. 
In addition, those individuals who initially indicated they would 
attend the in-person education but did not attend were called 
over the telephone and asked if they were willing to receive 
the brochure in the mail. If they were willing, they were 
switched to the brochure group. 
 
During the initial telephone call, those individuals who agreed 
to participate in the study received instructions appropriate to 
the intervention group to which they were assigned. For the 
in-person education, individuals were instructed over the 
phone of the time, date, location, and specific activities of the 
interactive event they would be attending. For the brochure 
group, individuals were informed that they would receive a 
pre-survey and informational brochure in the mail along with 
a return envelope in which to return the completed pre-
survey. 
 
Educational Interventions 
Although patients in different groups received education on 
MTM services in different educational formats, the core 
information about MTM services presented remained the 
same. Both the in-person education and brochure were 
designed to clearly convey the basics of MTM, an overview of 
patient benefits, the role of the pharmacist in MTM, and how 
to become enrolled in an MTM service.19 The Ohio Pharmacists 
Association and other pharmacy literature were used as a 
resource for this educational content. While the same 
information was being conveyed in both intervention groups, 
the presentation of information was very different for the 
intervention groups. The in-person education included a 
presenter, face-to-face interaction, visual aids, and time for 
questions. The informational brochure included factual 
information formatted with visuals to aid in clarity. 
 
Participants in the in-person education group were notified of 
the time and date of event during the initial recruitment phone 
call and were mailed a “save the date” postcard with 
information about the event, including time and date. A week 
prior to the event, all participants received another phone call 
to remind them of the time and location of the event and verify 
their attendance. In addition, a lunch was advertised and 
provided at the event to increase participant attendance.  
Participants completed a pre-survey at the beginning of the 
educational event.  The education session was approximately 
30 minutes in length. 
 
For those participants in the brochure group, the educational 
information was provided in a brochure distributed by mail. If 
the participant agreed to the study, they were sent the 
brochure and the pre-survey.  Participants were instructed to 
complete the pre-survey, then read the brochure.  This mailing 
also included a stamped, pre-addressed return envelope in 
which to mail back the completed pre-survey. After three 
weeks, those participants who still had not mailed back the 
pre-survey were called over the telephone to be reminded and 
sent a replacement survey with brochure in the mail. This was 
repeated after another three weeks if participants still had not 
responded. This method of reminding participants is based 
loosely on the Dillman method to maximize responses.20   
 
All participants then completed a post-survey one month after 
receiving the brochure or completing the educational event 
with the same mailing procedure (stamped, pre-addressed 
envelope, with reminders).  Figure 1 summarizes our process 
of participant recruitment, interventions, and data collection.  
 
Instruments 
First, relevant literature was examined to create the 
surveys.16,17 Before finalizing the survey content, it was 
reviewed for face and content validity. All surveys included 
instructions for completion that were developed specifically 
for either the brochure group or the in-person education 
group. The pre- and post-surveys had identical question 
content, with the exception of post-surveys having one 
additional question regarding patient enrollment in an MTM 
service. Surveys included 10 close-ended questions and 16 5-
point, Likert-type questions (1=Strongly Disagree, 5=Strongly 
Agree). Cronbach’s alpha for the surveys was 0.950, indicating 
good internal consistency.  The survey instrument can be 
found in Appendix 1. 
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Data Analysis 
All data collected through pre-and post-survey results was 
stored in password-protected Excel spreadsheets. IBM SPSS v. 
24.0 (Armonk, NY) was used to perform analyses, with all 
analyses based upon an alpha priori α value of 0.05 and a beta 
value of 0.8. Descriptive statistics were performed for all items.  
Wilcoxon Signed-Rank tests were used to examine changes in 
patient perceptions of MTM within groups, as appropriate. 
Mann Whitney-U tests and chi-squared tests were used to 
compare groups on perceptions of MTM, enrollment in MTM, 
or demographic characteristics, as appropriate.  
 
RESULTS 
A total of 35 participants completed the pre-education survey, 
with 10 in the in-person education group and 25 in the 
brochure group (Table 1). Most participants were between the 
ages of 45-54, female, Caucasian, had Medicaid insurance, and 
had a high school/GED degree or less. However, the in-person 
education group had a statistically significant (p<0.05) higher 
percentage of participants with some college education or 
higher. All participants made less than $30,000 a year. Lastly, 
most patients had not or were unsure if they had heard of 
MTM and had no knowledge that MTM services were fully 
covered by their insurance provider.  
 
There were no significant within-group differences for the 
brochure or in-person education groups. , but there were 
significant between-group differences (p<0.05) on 11 post-
assessment questions (Table 2).   
 
Table 3 displays the differences within the two groups for pre- 
and post-question responses. Neither group showed 
significant differences between their pre-survey and post-
survey responses within their group (p>0.05). Table 4 shows 
the number of participants that enrolled in an MTM service 
after the intervention. All in-person education participants 
who completed the assessments enrolled in MTM services, 
while no participants in the brochure group enrolled 
(p<0.001). 
 
DISCUSSION 
Results from our pre-post observational study serve to build 
upon previous research regarding patients’ perceptions and 
expectations about MTM services. Previous studies have 
shown that Medicare Part D enrollees who are eligible for 
MTM are widely unaware of the service. A study that 
administered surveys to 81 enrollees at four community 
pharmacies reported that 60% of respondents had never even 
heard of MTM services and 80-86% had never received MTM 
service components (medication therapy review, personal 
medication record, medication action plan).17 A second study 
that surveyed 504 Medicare Part D enrollees found that 93% 
of respondents were unaware of MTM services.16 Data from 
our surveys aligns well with this finding as 94.2% of our 
respondents were either unsure if they had heard of MTM 
(17.1%) or had never heard of MTM (77.1%). 
 
Both of these aforementioned studies surveying perceptions 
of Medicare Part D enrollees on MTM services also concluded 
that more education efforts are needed to educate the public 
about MTM and its benefits. Truong et al. even suggested 
brochures as a potential educational intervention as 50% of 
their survey respondents indicated that they would like to 
receive brochures or talk to their pharmacists to learn more 
about MTM.17 This reflects that patient desires do not always 
align with what is actually beneficial, as the findings of our 
study did not show that brochures were an effective 
educational method for educating patients on MTM. Huet et 
al. assessed the impact of passive and active promotional 
strategies on patient enrollment in MTM. Passive strategies 
included distribution of bag stuffers and mailed letters, and 
active strategies included face-to-face offers and telephone 
calls. While telephone calls resulted in the most amount of 
respondents participating in an MTM with a pharmacist, no 
significant differences between the four strategies was 
detected.18 
 
As previous research exposes the need for greater education 
of payers regarding MTM and inconclusive results as to 
effective means of education, our study served to help fill this 
gap by comparing personal and impersonal educational 
interventions. Findings from our data analysis indicated that 
while there were no significant differences within the two 
groups regarding differences in the pre- and post-surveys, the 
in-person education group reported significant differences in 
11 post-survey questions all showing changes from 
disagreement toward neutral or agreement. These differences 
included increased familiarity with MTM, stronger agreement 
with beliefs that MTM is beneficial, increased awareness of 
how to enroll in MTM, and increased likelihood of enrolling in 
MTM in the future. Not only did those individuals in the in-
person education group report increased positive perceptions 
of MTM, this group also had significantly increased actual 
enrollment in MTM compared to the brochure intervention 
group. This finding builds upon the results of Huet et al. as we 
were able to show significantly increased patient enrollment 
in MTM with in-person education, whereas Huet et al. was 
unable to detect a significant difference of passive and active 
promotional strategies on MTM enrollment.18  
 
These results support the finding that the impersonal brochure 
intervention was a less effective means of educating 
participants about MTM and impacting their enrollment of 
MTM. This is supported by results of a similar study performed 
in a TriCare beneficiary population that used mailing as a 
means of requesting participation in a medication review. Only 
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15.7% of their sample consented to participate in a medication 
review, and of these, only 9.7% returned a completed survey 
following the review.21 This strengthens the conclusion that 
using informational mailings as a means to garner MTM 
participation is not an effective use of resources.  
 
LIMITATIONS 
The main limitation of this study was a small sample size due 
to low respondent rates. Only a small portion of patients 
contacted were willing to consider participation in either 
intervention. Furthermore, those who agreed to participate 
largely did not return both required surveys and so could not 
be included in data analysis. The low response rate can 
partially be explained by  the low economic level of our sample 
population with potentially unreliable access to phone and 
mailing services, which were used as the primary means of 
communication in our study. A different means of contacting 
patients may have provided for a larger sample. To minimize 
this problem of low sample size, participants in the education 
group were provided with the incentive of lunch as well as 
multiple reminders to attend the educational session, and 
participants in both intervention groups were called multiple 
times to remind them to return surveys.  Offering the lunch 
could create bias for the in-person event, but despite these 
measures, overall participation and response rates were still 
low. The low respondent rates may also reflect a general lack 
of awareness about MTM and its impact on the initial 
willingness of patients to learn about MTM services.  
 
Use of a convenience sampling method subjects the findings 
to potential bias. Those patients who were willing to attend an 
educational event may have also been more likely to enroll in 
MTM services. In addition, there was a baseline difference in 
education between the education and brochure groups,  as the 
greatest percentage of the education group (60%) had 
received some college education and the greatest percentage 
of the brochure group (64%) had only achieved a high school 
education or equivalent. This may have impacted the 
differences detected between groups regarding perceptions of 
and enrollment in MTM. The patient demographic was mainly 
Caucasian women from the Springfield, OH region limiting the 
generalizability of our results.  
 
Lessons Learned 
Overall, the means of patient recruitment and data collection 
in this study were not very efficient with respect to cost, time, 
or outcomes. A large amount of time and resources were used 
making phone calls and managing mailings to a largely non-
responsive sample population. Participant retention was a 
major obstacle as only 19 of the initial 389 eligible patients 
(4.9%) completed all assessments. This exposes the need for 
an alternative method of recruiting patients and collecting 
results. The methods of survey distribution could be employed 
including e-mail or Internet surveys, but some study 
populations may have limited access, such as the population 
utilized in this study. Other educational strategies could be 
utilized in the future including dispersion of information using 
social media, educational posters posted in pharmacies, or 
even educating healthcare providers rather than patients so 
providers could refer their patients to an MTM service.  
 
CONCLUSIONS 
Results from this study help confirm the large patient 
unawareness of MTM services and need for greater education 
to increase awareness. These findings show that educating 
people in a personal face-to-face context had a more positive 
impact on perceptions of MTM and enrollment in MTM than 
through an impersonal education brochure. However, more 
research is needed to solidify these findings as previous 
literature is inconclusive in regards to best education methods, 
and this research was limited by a small sample size and low 
respondent rates. Areas of future research relevant to this 
topic include repeating this study using an alternative form of 
patient recruitment and data collection to increase the sample 
size, evaluating other forms of educational methods such as 
social media, educational posters, or direct education of health 
care providers, and measuring perceptions of MTM after 
patients participate in the service. 
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Table 1.  Demographics of Participants, n=35 (%) 
 
Demographic Percentage  
(In-Person Education 
Group n=10) 
Percentage 
 (Brochure Group 
n=25) 
Percentage 
(Total n=35) 
p-value 
Age (y)    0.198 
25-34 1 (10%) 3 (12%) 4 (11.4%)  
35-44 2 (20%) 2 (8%)  4 (11.4%)   
45-54 6 (60%) 10 (40%) 16 (45.7%)  
55-64 1 (10%) 10 (40%) 11 (31.4%)  
Gender     0.653 
Male  1 (10%) 5 (20%) 6 (17.1%)  
Female  9 (90%) 20 (80%) 29 (82.9%)  
Race/Ethnicity     0.321 
African American  3 (30%) 4 (16%) 7 (20%)  
Caucasian 7 (70%) 18 (72%) 25 (71.4%)  
Decline to Answer  -- 3 (12%) 3 (8.6%)  
Level of Education     0.015 
Less than High School  1 (10%) 3 (12%) 4 (11.4%)  
High School/GED  1 (10%) 16 (64%) 17 (48.6%)  
Some College  6 (60%) 5 (20%) 11 (31.4%)  
Two-Year College Degree 
(Associate’s)  
2 (20%) 1 (4%)  3 (8.6%)  
Household Yearly Income  1.000 
<$30,000 9 (90%) 25 (100%) 34 (97.1%)  
Missing  1 (10%) -- 1 (2.9%)  
Healthcare Professional  1.000 
No  10 (100%) 24 (96%) 1 (97.1%)  
Missing  -- 1 (4%) 1 (2.9%)  
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Insurance     0.872 
Medicare only  1 (10%) -- 1 (2.9%)  
Medicaid only (e.g. Caresource)  8 (80%) 24 (96%) 32 (91.4%)  
Other  1 (10%) 1 (4%) 2 (5.7%)  
Heard of MTM    0.517 
Yes  -- 2 (8%) 2 (5.7%)  
No  8 (80%) 19 (76%) 27 (77.1%)  
Unsure  2 (20%) 4 (16%) 6 (17.1%)  
Knowledge of Eligibility for Free MTM Coverage through Insurance  0.604 
Yes  1 (10%) 2 (8%) 3 (8.6%)  
No  4 (40%) 8 (32%) 12 (34.3%)  
Unsure  5 (50%) 15 (60%)  20 (57.1%)  
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Table 2. Differences Between Groups for Pre and Post-Survey  
Responses on their Knowledge and Perceptions of MTM Services 
 
 Pre-Test Post-Test Education vs. 
Brochure 
Pre-test 
p-value 
Education vs. 
Brochure Post-
test 
p-value 
Itemsa Education 
Group 
Median 
Brochure 
Group 
Median 
Education 
Group 
Median 
Brochure 
Group 
Median 
1. I am familiar with what 
an MTM service is.  
1 1 3 1.5 0.254 0.047 
2. I am familiar with the 
different parts involved 
with MTM services.  
1 1 3 1 0.341 0.014 
3. I am familiar with who 
provides MTM services.  
1 1 3 1 0.090 0.014 
4. I am familiar with the 
term Personal Medication 
Record (PMR). 
2 2 3 2 0.627 0.064 
5. I am familiar with the 
term Medication Action 
Plan (MAP).  
1 1 3 1 0.303 0.033 
6. My current health 
condition makes me a 
good candidate for MTM 
services.  
2 2 3 2 1.000 0.047 
7. Using MTM services 
would help me get the 
most out of my 
medications.  
2 2 3 2 0.815 0.047 
8. Using MTM services 
would help save me 
money on my 
medications.  
2 2 3 2 0.969 0.254 
9. Using MTM services 
could keep me from 
having to go to the 
hospital.  
2 2 2 2 0.602 0.875 
10. Using MTM services 
would help make sure 
that I am taking all of my 
medications safely. 
2 2 4 3 0.553 0.023 
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11. Using MTM services 
would help make sure 
that I am taking all of my 
medications correctly.  
2 2 4 2 0.872 0.014 
12. Using MTM services 
would benefit my health 
condition overall.  
2 2 3 2 0.679 0.303 
13. I know how to sign up 
for MTM services if I 
would want to.  
1 2 3 1.5 0.174 0.014 
14. The benefits of MTM 
services are worth having 
to go to an appointment.  
2 2 3 2 0.928 0.033 
15. I am likely to use 
MTM services in the 
future.  
2 2 3 2 0.553 0.033 
a1=Strongly Disagree, 2=Disagree, 3=Neutral, 4=Agree, 5=Strongly Agree 
Statistical Test: Mann Whitney U 
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Table 3. Differences Within Groups for Completed Pre- and Post-Survey 
Responses on their Knowledge and Perceptions of MTM Services (p value) 
 
Item In-Person Education (n=3) Brochure (n=16) 
Question 1 0.102 0.142 
Question 2 0.109 0.257 
Question 3 0.109 0.527 
Question 4 0.157 0.942 
Question 5 0.102 0.248 
Question 6 0.102 0.739 
Question 7 0.180 0.414 
Question 8 0.180 0.084 
Question 9 0.655 1.000 
Question 10 0.102 0.317 
Question 11 0.102 0.157 
Question 12 0.317 0.705 
Question 13 0.102 0.187 
Question 14 0.102 1.000 
Question 15 0.180 0.317 
 
 
 
Table 4.  Report of Enrollment in MTM Service 
 
Responsea Total (n=19) In-Person Education (n=3) Brochure (n=16) 
Yes 3 (16%) 3 (100%) 0 (0%) 
No 11 (58%) 0 (0%)  11 (69%) 
Unsure 5 (26%) 0 (0%) 5 (31%) 
aSignificant difference in enrollment between in-person and brochure, as assessed by a Chi-square test, p value 
≤ 0.001 
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Figure 1: Flowchart of Intervention Methods
 
 
